Genoptix Inc has announced that it will participate in Aetna’s (AET) national provider network to offer specialized laboratory and comprehensive diagnostic services designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma.
Read MoreQuest Diagnostics will present new discoveries during the 51st American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans.
Read MoreChina Medical Technologies Inc, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe from the State Food and Drug Administration of China (SFDA).
Read More
The labs at BryanLGH Medical Center save time and increase accuracy with the IG parameter from Sysmex.
Read MoreMolecularMD Corp announced that it has granted a sub-license agreement for the detection of ABL kinase mutations in Chronic Myelogenous Leukemia (CML) patients to the Mayo Clinic.
Read More